Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734311) titled 'A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Condition:
Knee Osteoarthritis
Obesity
Intervention:
Drug: Ecnoglutide Injection
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: July 31, 2026
Target Sample Size: 360
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/...